During the past decade, Wake Nephrology Associates, PA conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wake Nephrology Associates, PA" #1 sponsor was "C. R. Bard" with 4 trials, followed by "Pfizer" with 2 trials sponsored, "Trevi Therapeutics" with 2 trials sponsored, "Abbott" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wake Nephrology Associates, PA" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Wake Nephrology Associates, PA" are "Arteriovenous Fistula" (2 trials), "Arteriovenous Fistula Stenosis" (2 trials), "Pruritus" (2 trials), "Restenosis" (2 trials) and "Stenosis" (2 trials). Many other conditions were trialed in "Wake Nephrology Associates, PA" in a lesser frequency.

Most popular intervention types in "Wake Nephrology Associates, PA" are "Device" (6 trials), "Drug" (6 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Epoetin Hospira" (2 trials), "Angioplasty" (1 trials), "Covera Vascular Covered Stent" (1 trials), "Covera Vascular Covered Stent following PTA" (1 trials) and "Covera(TM) Vascular Covered Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wake Nephrology Associates, PA" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Wake Nephrology Associates, PA". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Wake Nephrology Associates, PA, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Wake Nephrology Associates, PA, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".